申请人:Santhera Pharmaceuticals (Deutschland)
Aktiengesellschaft
公开号:EP1598341A8
公开(公告)日:2006-03-01
The invention relates to compounds of formula (I)
wherein Z, R1-8, n, A1, X1 and X2 have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
该发明涉及具有如下式(I)的化合物,其中Z、R1-8、n、A1、X1和X2的含义如描述和权利要求中所述。所述化合物可用作DPP-IV抑制剂。该发明还涉及制备此类化合物以及其作为药物的生产和使用。